Lovastatin suppresses hyperexcitability and seizure in Angelman syndrome model

被引:22
作者
Chung, Leeyup [1 ,5 ]
Bey, Alexandra L. [2 ]
Towers, Aaron J. [3 ]
Cao, Xinyu [1 ]
Kim, Il Hwan [4 ]
Jiang, Yong-hui [1 ,2 ,3 ]
机构
[1] Duke Univ, Sch Med, Dept Pediat, Durham, NC 27710 USA
[2] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA
[3] Duke Univ, Sch Med, Univ Program Genet & Genom, Durham, NC 27710 USA
[4] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA
[5] Korea Brain Res Inst, 61 Cheomdan Ro, Daegu 41068, South Korea
关键词
Angelman syndrome; Ube3a; Seizure; Lovastatin; Long burst; FRAGILE-X-SYNDROME; MOUSE MODEL; EPILEPTIFORM DISCHARGES; MENTAL-RETARDATION; SYNAPTIC PLASTICITY; AUDIOGENIC-SEIZURES; EEG ABNORMALITIES; PROTEIN-SYNTHESIS; UBIQUITIN LIGASE; IN-VITRO;
D O I
10.1016/j.nbd.2017.10.016
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Epilepsy is prevalent and often medically intractable in Angelman syndrome (AS). AS mouse model (Ube3a(m - /P +)) shows reduced excitatory neurotransmission but lower seizure threshold. The neural mechanism linking the synaptic dysfunction to the seizure remains elusive. We show that the local circuits of Ube3a(m - /P +) in vitro are hyperexcitable and display a unique epileptiform activity, a phenomenon that is reminiscent of the finding in fragile X syndrome (FXS) mouse model. Similar to the FXS model, lovastatin suppressed the epileptiform activity and audiogenic seizures in Ube3a(m - /P +). The in vitro model of Ube3a(m - /P +) is valuable for dissection of neural mechanism and epilepsy drug screening in vivo.
引用
收藏
页码:12 / 19
页数:8
相关论文
共 61 条
  • [1] FMRP targets distinct mRNA sequence elements to regulate protein expression
    Ascano, Manuel, Jr.
    Mukherjee, Neelanjan
    Bandaru, Pradeep
    Miller, Jason B.
    Nusbaum, Jeffrey D.
    Corcoran, David L.
    Langlois, Christine
    Munschauer, Mathias
    Dewell, Scott
    Hafner, Markus
    Williams, Zev
    Ohler, Uwe
    Tuschl, Thomas
    [J]. NATURE, 2012, 492 (7429) : 382 - +
  • [2] Statins - Are they anticonvulsant?
    Banach, Monika
    Czuczwar, Stanislaw J.
    Borowicz, Kinga K.
    [J]. PHARMACOLOGICAL REPORTS, 2014, 66 (04) : 521 - 528
  • [3] Angelman syndrome - insights into a rare neurogenetic disorder
    Buiting, Karin
    Williams, Charles
    Horsthemke, Bernhard
    [J]. NATURE REVIEWS NEUROLOGY, 2016, 12 (10) : 584 - 593
  • [4] Effect of Lovastatin on Behavior in Children and Adults with Fragile X Syndrome: An Open-Label Study
    Caku, Artuela
    Pellerin, David
    Bouvier, Pamela
    Riou, Emilie
    Corbin, Francois
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2014, 164 (11) : 2834 - 2842
  • [5] Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model
    Chuang, SC
    Zhao, WF
    Bauchwitz, R
    Yan, QJ
    Bianchi, R
    Wong, RKS
    [J]. JOURNAL OF NEUROSCIENCE, 2005, 25 (35) : 8048 - 8055
  • [6] Protective effects of some statins on epileptogenesis and depressive-like behavior in WAG/Rij rats, a genetic animal model of absence epilepsy
    Citraro, Rita
    Chimirri, Serafina
    Aiello, Rossana
    Gallelli, Luca
    Trimboli, Francesca
    Britti, Domenico
    De Sarro, Giovambattista
    Russo, Emilio
    [J]. EPILEPSIA, 2014, 55 (08) : 1284 - 1291
  • [7] Altered Neuronal and Circuit Excitability in Fragile X Syndrome
    Contractor, Anis
    Klyachko, Vitaly A.
    Portera-Cailliau, Carlos
    [J]. NEURON, 2015, 87 (04) : 699 - 715
  • [8] Angelman syndrome: Current understanding and research prospects
    Dan, Bernard
    [J]. EPILEPSIA, 2009, 50 (11) : 2331 - 2339
  • [9] DeLorey TM, 1998, J NEUROSCI, V18, P8505
  • [10] Aberrant somatosensory-evoked responses imply GABAergic dysfunction in Angelman syndrome
    Egawa, Kiyoshi
    Asahina, Naoko
    Shiraishi, Hideaki
    Kamada, Kyousuke
    Takeuchi, Fumiya
    Nakane, Shingo
    Sudo, Akira
    Kohsaka, Shinobu
    Saitoh, Shinji
    [J]. NEUROIMAGE, 2008, 39 (02) : 593 - 599